InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Bhowmick Neil. Director active across 1 company, notably Kairos Pharma, LTD.. Aggregated, 2 disclosures have been published. Activity tracked since 1 January 2025. The latest transaction was filed on 8 October 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations